The reclassification doesn't suddenly make pot legal in the U.S., but it does mark an important shift in the country's ...

The order places FDA-approved products containing marijuana and state-regulated medical marijuana products at a lower drug ...

The table below is a review of notable updates that occurred in March 2026 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.

Novo Nordisk (NVO) stock gains after oral semaglutide pill succeeds in pediatric type 2 diabetes trial. Company targets H2 ...

Police spotted drugs after being invited into a property in Stafford. Bungling Malcolm David Arnold left cocaine on a bedside ...

Acting Attorney General Todd Blanche signed an order Thursday reclassifying state-licensed marijuana as a less dangerous drug ...

A few common medications, like statins or drugs to treat high blood pressure, appear to help lower the risk for dementia. But ...

Cymbalta and Lexapro are both used to treat depression and anxiety disorders, but they are different drug classes. Cymbalta is also approved to treat nerve pain and fibromyalgia in adults. Lexapro ...

Objective Drug-related problems (DRPs), which encompass medication errors (MEs), adverse drug reactions and adverse drug events (ADEs), represent significant challenges in healthcare settings. While ...

In a major change to federal marijuana policy, President Donald Trump signed an executive order in December to classify marijuana as a less dangerous substance. On Dec. 18, the president ordered the ...

For more than 50 years, marijuana has been classified as a Schedule I drug, alongside drugs considered to have no accepted medical use, thanks to then-President Richard Nixon’s so-called War on Drugs.